Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Portier

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1990
Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbitsP Chavanet, E Muggeo, A Waldner, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniaeN Desbiolles, L Piroth, C Lequeu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 10, 2005
Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factorsH Portier, C Brambilla, M Garre, et al.
Pathologie-Biologie|May 1, 1987
[Treatment of bacterial infections by ofloxacin. 42 cases]P Chavanet, S Arnould, Y Sarret, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2000
Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapyL Piroth, M Grappin, M Buisson, et al.
Medecine Et Maladies Infectieuses|January 29, 2005
[Invasive Streptococcus pyogenes infections]C Veyssier-Belot, D Lévy-Bruhl, G Carret, et al.
Pathologie-Biologie|June 1, 1984
[Cerebrospinal fluid diffusion kinetics of cefotaxime and fosfomycin in Staphylococcus aureus meningitis with otorrhea]J C Tremeaux, H Portier, J L Sautreaux, et al.
Presse Medicale (Paris, France : 1983)|December 16, 1987
[Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)]H Guy, D Caillot, E Solary, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1986
[Vesiculo-bullous lupus erythematosus. Immuno-electronic study]D Lambert, F Beer, W Godard, et al.
AIDS (London, England)|September 1, 1994
A case of rhombencephalitis with isolation of cytomegalovirus and Mycobacterium avium complex in a woman with AIDSM Duong, L Piroth, P Chavanet, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1990
Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbitsP Chavanet, E Muggeo, A Waldner, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniaeN Desbiolles, L Piroth, C Lequeu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 10, 2005
Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factorsH Portier, C Brambilla, M Garre, et al.
Pathologie-Biologie|May 1, 1987
[Treatment of bacterial infections by ofloxacin. 42 cases]P Chavanet, S Arnould, Y Sarret, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2000
Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapyL Piroth, M Grappin, M Buisson, et al.
Medecine Et Maladies Infectieuses|January 29, 2005
[Invasive Streptococcus pyogenes infections]C Veyssier-Belot, D Lévy-Bruhl, G Carret, et al.
Pathologie-Biologie|June 1, 1984
[Cerebrospinal fluid diffusion kinetics of cefotaxime and fosfomycin in Staphylococcus aureus meningitis with otorrhea]J C Tremeaux, H Portier, J L Sautreaux, et al.
Presse Medicale (Paris, France : 1983)|December 16, 1987
[Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)]H Guy, D Caillot, E Solary, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1986
[Vesiculo-bullous lupus erythematosus. Immuno-electronic study]D Lambert, F Beer, W Godard, et al.
AIDS (London, England)|September 1, 1994
A case of rhombencephalitis with isolation of cytomegalovirus and Mycobacterium avium complex in a woman with AIDSM Duong, L Piroth, P Chavanet, et al.
Pageof 15